Billionaire Profile
Vikram Punia
Global Rank
#1997

Image: Unsplash Contributor | Unsplash License | via Unsplash

Vikram Punia

CEO, Pharmaceuticals
RUSSIA
Real-Time Net Worth
$2.03B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
0% (24h)
Age
52
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
RUSSIA

Biography

Vikram Punia is a prominent Russian billionaire and pharmaceutical magnate, born in India. His journey began in 1992 when he moved to Russia as a student. He is the sole owner of Pharmasyntez, a leading Russian pharmaceutical company. His primary source of wealth is the pharmaceutical industry. With a net worth of $2.1 billion, Punia's career has been marked by innovation and a commitment to providing affordable medicines, particularly for the treatment of critical illnesses. He is also involved in efforts to promote cooperation between India and Russia in the business sector.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Vikram Singh Punia was born in Jaipur, Rajasthan, India, in 1973. He completed his schooling in Rajasthan and graduated from Birla High School in Pilani. At the age of 19, in 1992, he moved to Russia through a student exchange program to pursue higher education in medicine.

Rise to Success

Punia founded Pharmasyntez in 1997 in Irkutsk, Russia. The company started by repackaging generic antitubercular medicine imported from India. Pharmasyntez quickly grew into a leading supplier of drugs under government contracts, producing a wide range of medicines, including those for HIV, cancer, and other serious illnesses. He became a Russian citizen in 2009 and relocated the company's headquarters to Moscow in 2008. He is the sole owner of Pharmasyntez.

Key Business Strategies

Pharmasyntez has focused on producing affordable, high-quality medicines, including those for socially significant diseases. The company has expanded its operations with multiple plants across Russia. Punia has emphasized innovation and the development of strategic projects in both Russian and global markets.

Philanthropy

Specific details of Punia's philanthropic initiatives are not readily available in the search results, but his company provides affordable treatments for various diseases, indicating a commitment to improving public health.

Career Milestones

1992

Moved to Russia

Moved to Russia through a student exchange program.

1997

Founded Pharmasyntez

Founded Pharmasyntez, a pharmaceutical company in Irkutsk, Russia.

2009

Became a Russian citizen

Obtained Russian citizenship.

2010

Sole Owner of Pharmasyntez

Became the sole owner of Pharmasyntez.

2017

Board Member, India-Russia Business Cooperation Council

Became a board member assisting Indian entrepreneurs in Russia.

Philanthropy & Social Impact

Healthcare

Affordable Medicines

Undisclosed

Pharmasyntez provides affordable medicines for treating HIV, cancer, and other serious illnesses.

Business Philosophy & Leadership

Notable Quotes

""To make life better, we should cooperate...""

Leadership Principles

Innovation

Focus on developing new technologies and implementing international standards in pharmaceutical manufacturing.

Strategic Vision

Expanding Pharmasyntez's presence in both Russian and global markets.

Commitment to Affordable Healthcare

Providing high-quality and affordable medicines for various diseases.

Controversies & Challenges

N/A

Allegations of Financial Misconduct

Some reports suggest that there might be questionable financial practices within Pharmasyntez, though details are not fully available.